Zinc oxide paste bandages and stockings: EVOLAN.
- Published in:
- Journal of Community Nursing, 2025, v. 39, n. 3, p. 22
- By:
- Publication type:
- Article
Works matching DE "PHARMACY information services"
Results: 1563
1
2
Evaluation of Pharmacist Involvement in Emergency Response.
- Published in:
- Journal of Pharmacy Practice, 2025, v. 38, n. 4, p. 403, doi. 10.1177/08971900241310308
- By:
- Publication type:
- Article
3
FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer.
- Published in:
- ONS Voice, 2025, p. N.PAG
- Publication type:
- Article
4
Clozapine in the Spotlight: Understanding the Recent Clozapine REMS Changes and a Research Update for 2025.
- Published in:
- Issues in Mental Health Nursing, 2025, v. 46, n. 6, p. 633, doi. 10.1080/01612840.2025.2503132
- By:
- Publication type:
- Article
5
Your Medication Information.
- Published in:
- Brown University Psychopharmacology Update, 2025, v. 36, n. 7, p. 9, doi. 10.1002/pu.31259
- Publication type:
- Article
6
Tapentadol – nowy opioid o unikalnym, podwójnym mechanizmie działania i szerokich możliwościach zastosowania – przegląd danych klinicznych.
- Published in:
- Pain Research / Ból, 2025, v. 26, n. 1, p. 26, doi. 10.5604/01.3001.0055.0947
- By:
- Publication type:
- Article
7
Patient Information Sheet.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2025, v. 27, n. 6, p. 9, doi. 10.1002/cpu.30981
- By:
- Publication type:
- Article
8
QUIMIO EM CASA: APPLICATION FOR FAMILY MEMBERS OF CHILDREN AND ADOLESCENTS USING ORAL ANTINEOPLASTIC AGENTS.
- Published in:
- Texto & Contexto Enfermagem, 2022, v. 31, p. 1, doi. 10.1590/1980-265X-TCE-2021-0414en
- By:
- Publication type:
- Article
9
Zuranolone: A Breakthrough in the Treatment of Postpartum Depression.
- Published in:
- Journal of Women's Health (15409996), 2024, v. 33, n. 4, p. 407, doi. 10.1089/jwh.2023.0991
- By:
- Publication type:
- Article
10
Practical Clinical Technologies.
- Published in:
- Bio-IT World, 2005, v. 4, n. 4, p. 58
- By:
- Publication type:
- Article
11
Evaluation of quality and readability of online patient information on osteoporosis and osteoporosis drug treatment and recommendations for improvement.
- Published in:
- Osteoporosis International, 2021, v. 32, n. 8, p. 1567, doi. 10.1007/s00198-020-05800-7
- By:
- Publication type:
- Article
12
Towards streamlined product information: reporting of transporter-mediated drug interactions.
- Published in:
- European Journal of Clinical Pharmacology, 2025, v. 81, n. 1, p. 151, doi. 10.1007/s00228-024-03772-9
- By:
- Publication type:
- Article
13
Estimating the impact of label design on reducing the risk of medication errors by applying HEART in drug administration.
- Published in:
- European Journal of Clinical Pharmacology, 2024, v. 80, n. 4, p. 575, doi. 10.1007/s00228-024-03619-3
- By:
- Publication type:
- Article
14
Will artificial intelligence chatbots replace clinical pharmacologists? An exploratory study in clinical practice.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 10, p. 1375, doi. 10.1007/s00228-023-03547-8
- By:
- Publication type:
- Article
15
Medicines postpartum in Sweden and coverage in Janusmed Breastfeeding.
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 9, p. 1261, doi. 10.1007/s00228-023-03528-x
- By:
- Publication type:
- Article
16
Drug information sources in professional work—a questionnaire study on physicians' usage and preferences (the drug information study).
- Published in:
- European Journal of Clinical Pharmacology, 2023, v. 79, n. 6, p. 767, doi. 10.1007/s00228-023-03494-4
- By:
- Publication type:
- Article
17
Evolution of adverse drug reactions reporting systems: paper based to software based.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 9, p. 1385, doi. 10.1007/s00228-022-03358-3
- By:
- Publication type:
- Article
18
Loncastuximab tesirine: an effective therapy for relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 5, p. 707, doi. 10.1007/s00228-021-03253-3
- By:
- Publication type:
- Article
19
Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances.
- Published in:
- European Journal of Clinical Pharmacology, 2022, v. 78, n. 3, p. 419, doi. 10.1007/s00228-021-03209-7
- By:
- Publication type:
- Article
20
Dasiglucagon: an effective medicine for severe hypoglycemia.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 12, p. 1783, doi. 10.1007/s00228-021-03183-0
- By:
- Publication type:
- Article
21
Disproportionality analysis for identification of drug safety signals in a database shared by the Norwegian network of drug information centres (RELIS).
- Published in:
- 2019
- By:
- Publication type:
- Letter
22
Fall-risk-increasing adverse reactions—is there value in easily accessible drug information? A case-control study.
- Published in:
- European Journal of Clinical Pharmacology, 2019, v. 75, n. 6, p. 849, doi. 10.1007/s00228-019-02628-x
- By:
- Publication type:
- Article
23
Clinical pharmacology in Stockholm 50 years—report from the jubilee symposium.
- Published in:
- 2018
- By:
- Publication type:
- Conference Paper/Materials
24
Drug safety in pregnancy: the German Embryotox institute.
- Published in:
- European Journal of Clinical Pharmacology, 2018, v. 74, n. 2, p. 171, doi. 10.1007/s00228-017-2351-y
- By:
- Publication type:
- Article
25
Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres.
- Published in:
- European Journal of Clinical Pharmacology, 2017, v. 73, n. 5, p. 623, doi. 10.1007/s00228-017-2209-3
- By:
- Publication type:
- Article
26
Benefits of a national network of drug information centres: RELIS.
- Published in:
- 2017
- By:
- Publication type:
- Letter
27
Medication use and drug-related problems among women at maternity wards-a cross-sectional study from two Norwegian hospitals.
- Published in:
- European Journal of Clinical Pharmacology, 2016, v. 72, n. 7, p. 849, doi. 10.1007/s00228-016-2042-0
- By:
- Publication type:
- Article
28
Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 11, p. 1395, doi. 10.1007/s00228-014-1749-z
- By:
- Publication type:
- Article
29
Inappropriate crushing information on ward lists: cytotoxic drugs, capsules, and modified release formulations are gravely neglected.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 5, p. 565, doi. 10.1007/s00228-013-1638-x
- By:
- Publication type:
- Article
30
Exploring the perspectives of potential consumers and healthcare professionals on the readability of a package insert: a case study of an over-the-counter medicine.
- Published in:
- European Journal of Clinical Pharmacology, 2014, v. 70, n. 5, p. 583, doi. 10.1007/s00228-014-1645-6
- By:
- Publication type:
- Article
31
Clinical pharmacology in everyday clinical care.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, p. 89, doi. 10.1007/s00228-013-1490-z
- By:
- Publication type:
- Article
32
The continuing challenge of providing drug information services to diminish the knowledge-practice gap in medical practice.
- Published in:
- European Journal of Clinical Pharmacology, 2013, v. 69, p. 65, doi. 10.1007/s00228-013-1484-x
- By:
- Publication type:
- Article
33
Separating the wheat from the chaff: essential information in therapeutics.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
34
Identification of severe potential drug-drug interactions using an Italian general-practitioner database.
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 3, p. 303, doi. 10.1007/s00228-007-0394-1
- By:
- Publication type:
- Article
35
Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians?
- Published in:
- European Journal of Clinical Pharmacology, 2002, v. 57, n. 12, p. 897, doi. 10.1007/s00228-001-0386-5
- By:
- Publication type:
- Article
36
Why neutralizing antibodies remain vital in SARS-CoV-2 variants and vaccines.
- Published in:
- Medical Laboratory Observer (MLO), 2021, v. 53, n. 4, p. 46
- By:
- Publication type:
- Article
37
Public Understanding of Risk and Benefit of Mifepristone: A Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2025, v. 8, n. 2, p. e2460236, doi. 10.1001/jamanetworkopen.2024.60236
- By:
- Publication type:
- Article
38
Consumer Perceptions of Safety Information in Direct-to-Consumer Print Advertisements for Alzheimer Drugs.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 8, p. e2431110, doi. 10.1001/jamanetworkopen.2024.31110
- By:
- Publication type:
- Article
39
Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2419851, doi. 10.1001/jamanetworkopen.2024.19851
- By:
- Publication type:
- Article
40
The “sixth right” of medication use: Medication without harm.
- Published in:
- Journal of Patient Safety & Risk Management, 2019, v. 24, n. 1, p. 3, doi. 10.1177/2516043519828027
- By:
- Publication type:
- Article
41
Retrospective analysis of adverse drug reaction enquiries to a hospital drug information service: Lessons to be learned to increase in-hospital drug safety.
- Published in:
- Pharmacy Research Review, 2024, n. 92, p. 2
- By:
- Publication type:
- Article
42
Performance of the ChatGPT large language model for decision support in community pharmacy.
- Published in:
- Pharmacy Research Review, 2024, n. 93, p. 1
- By:
- Publication type:
- Article
43
Factors determining quality of drug information by hospital pharmacies - results from five-year annual quality assessment.
- Published in:
- 2024
- By:
- Publication type:
- Abstract
44
Performance and risks of ChatGPT used in drug information: An exploratory real-world analysis.
- Published in:
- Pharmacy Research Review, 2023, n. 86, p. 1
- By:
- Publication type:
- Article
45
Identifying target areas of medicines information efforts to pregnant and breastfeeding women by reviewing questions to SafeMotherMedicine: A Norwegian web-based public medicines information service.
- Published in:
- Pharmacy Research Review, 2023, n. 84, p. 4
- By:
- Publication type:
- Article
46
Welcome to the latest issue of Pharmacy Research Review.
- Published in:
- Pharmacy Research Review, 2023, n. 86, p. 1
- By:
- Publication type:
- Article
47
Scaling-up a pharmacistled information technology intervention (PINCER) to reduce hazardous prescribing in general practices: Multiple interrupted time series study.
- Published in:
- Pharmacy Research Review, 2022, n. 83, p. 3
- Publication type:
- Article
48
Welcome to the latest issue of Pharmacy Research Review.
- Published in:
- Pharmacy Research Review, 2022, n. 79, p. 1
- By:
- Publication type:
- Article
49
Oncology Drug Reference Sheet: 5-Fluorouracil.
- Published in:
- ONS Voice, 2024, p. 2
- By:
- Publication type:
- Article
50
FDA Approves Daratumumab and Hyaluronidase-Fihj With Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
- Published in:
- ONS Voice, 2024, p. 1
- Publication type:
- Article